Latest News and Press Releases
Want to stay updated on the latest news?
-
Inivata Announces Collaboration with Maverick Therapeutics for use of RaDaR™ Assay RaDaR ctDNA liquid biopsy test to be used to monitor patient response in Phase 1/2 study of MVC-101 in multiple...
-
Inivata Appoints Peter Collins as Chief Business Officer Research Triangle Park, NC, USA and Cambridge, UK, 22 September 2020 – Inivata, a leader in liquid biopsy, today announces the...
-
US Commercial Launch of InVisionFirst®-Lung Inivata’s Liquid Biopsy Test for Advanced Non-Small Cell Lung Cancer is Now Available Through NeoGenomics in the US Research Triangle Park, NC, USA and...
-
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay Personalized assay for detection of residual disease and recurrence...
-
Inivata Joins Blood Profiling Atlas in Cancer (BloodPAC) Consortium Research Triangle Park, NC, USA and Cambridge, UK, 18 June 2020 - Inivata, a leader in liquid biopsy, announces that it has...
-
Inivata and Collaborators to Present New Data from the RaDaR™ Assay at AACR Virtual Annual Meeting II Data will showcase capabilities of newly launched liquid biopsy assay for the detection of...
-
Inivata Announces Strategic Collaboration and Investment from NeoGenomics NeoGenomics will commercialize Inivata’s InVisionFirst®-Lung liquid biopsy test in the United States Inivata and...
-
Inivata Offers Mobile Phlebotomy Services for patients undergoing InVisionFirst® Lung ctDNA liquid biopsy Research Triangle Park, NC, USA May 12, 2020 – Inivata (www.inivata.com) a leader in...
-
Inivata Launches RaDaR™ Assay for Detection of Residual Disease and Recurrence Personalized multi-tumor test provides potential new option for the rapid and sensitive identification of...
-
Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study Inivata to...